Fogelman, Nia
Schwartz, Julie
Chaplin, Tara M.
Jastreboff, Ania M.
Silverman, Wendy K.
Sinha, Rajita http://orcid.org/0000-0003-3012-4349
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK117651)
National Center for Complementary and Integrative Health (R21-AT007708)
Article History
Accepted: 14 May 2022
First Online: 8 June 2022
Declarations
:
: A.M. Jastreboff is on the Scientific Advisory Board/Consultant for Novo Nordisk, Eli Lilly, Boehringer Ingelheim, Intellihealth, Scholar Rock, Pfizer, and Rhythm Pharmaceuticals. All other authors have no disclosures or conflicts of interest to report.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.